Revenue, last quarter
$422K
Net income
−$2.5M
EPS, diluted
-
Operating cash flow
−$568K
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.3M | −$7.1M |
| FY24 | $1.3M | −$13M |
| FY23 | $911K | −$11.5M |
| FY22 | $397K | −$15M |
| FY21 | $898K | −$8.8M |
| FY20 | $4.1M | −$7.3M |
| FY19 | $5.1M | −$4.1M |
| FY18 | $2.2M | −$1.8M |
| FY17 | $580.4K | −$1.9M |
| FY16 | $6.4M | −$2.8M |
| FY15 | $7.7M | −$4.6M |
| FY14 | $2.3M | −$3M |
| FY13 | $8M | −$2.3M |
| FY12 | $4.2M | −$7.8M |
| FY11 | $4.1M | −$20.2M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 48.7% | −585.8% | −560.3% |
| FY24 | 54.5% | −728.5% | −966.5% |
| FY23 | 48.5% | −1270.1% | −1263% |
| FY22 | 48.9% | −3886.1% | −3782.4% |
| FY21 | 12.6% | −971.5% | −981.2% |
| FY20 | 2.8% | −168.6% | −179.6% |
| FY19 | 2.6% | −90.8% | −80.1% |
| FY18 | 3.7% | −81.6% | −81.4% |
| FY17 | 37.6% | −354% | −321.7% |
| FY16 | 13.2% | −45.6% | −44.1% |
| FY15 | 7.5% | −56.5% | −60.1% |
| FY14 | 16.8% | −111.2% | −133% |
| FY13 | 19.1% | −30.9% | −28% |
| FY12 | −14.7% | −178.9% | −184.6% |
| FY11 | 3.9% | −390% | −496.8% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$4.9M |
| FY24 | −$5.3M |
| FY23 | −$7.4M |
| FY22 | −$7.7M |
| FY21 | −$12.3M |
| FY20 | −$13.1M |
| FY19 | −$3.3M |
| FY18 | −$2.1M |
| FY17 | −$1.5M |
| FY16 | −$279.9K |
| FY15 | −$2.7M |
| FY14 | −$1.8M |
| FY13 | $238.8K |
| FY12 | −$5M |
| FY11 | −$2.9M |
- IGC Pharma
- Healthcare median
Show the numbers
| Year | IGC Pharma | Healthcare median |
|---|---|---|
| FY25 | −560.3% | −30.6% |
| FY24 | −966.5% | −47% |
| FY23 | −1263% | −58% |
| FY22 | −3782.4% | −80.4% |
| FY21 | −981.2% | −71.9% |
| FY20 | −179.6% | −62.2% |
| FY19 | −80.1% | −46.3% |
| FY18 | −81.4% | −49.6% |
| FY17 | −321.7% | −45.9% |
| FY16 | −44.1% | −36% |
| FY15 | −60.1% | −38.4% |
| FY14 | −133% | −35.5% |
| FY13 | −28% | −37.1% |
| FY12 | −184.6% | −29.1% |
| FY11 | −496.8% | −27.9% |